1576 related articles for article (PubMed ID: 24089155)
1. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
Teruel-Briones JL; Fernández-Lucas M; Rivera-Gorrin M; Ruiz-Roso G; Díaz-Domínguez M; Rodríguez-Mendiola N; Quereda-Rodríguez-Navarro C
Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155
[TBL] [Abstract][Full Text] [Related]
2. Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen.
Fernández-Lucas M; Teruel-Briones JL; Gomis-Couto A; Villacorta-Pérez J; Quereda-Rodríguez-Navarro C
Nefrologia; 2012; 32(6):767-76. PubMed ID: 23169359
[TBL] [Abstract][Full Text] [Related]
3. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis.
Rottembourg J; Issad B; Gallego JL; Degoulet P; Aime F; Gueffaf B; Legrain M
Proc Eur Dial Transplant Assoc; 1983; 19():397-403. PubMed ID: 6878254
[TBL] [Abstract][Full Text] [Related]
4. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
Stojimirović B; Grujić-Adanja G
Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
[TBL] [Abstract][Full Text] [Related]
5. Incremental dialysis with automated peritoneal dialysis.
Neri L; Viglino G; Cappelletti A; Gandolfo C; Barbieri S
Adv Perit Dial; 2003; 19():93-6. PubMed ID: 14763041
[TBL] [Abstract][Full Text] [Related]
6. Independent effects of residual renal function and dialysis adequacy on nutritional status and patient outcome in continuous ambulatory peritoneal dialysis.
Szeto CC; Lai KN; Wong TY; Law MC; Leung CB; Yu AW; Li PK
Am J Kidney Dis; 1999 Dec; 34(6):1056-64. PubMed ID: 10585315
[TBL] [Abstract][Full Text] [Related]
7. Impact of combination therapy with peritoneal dialysis and hemodialysis on peritoneal function.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2010; 26():67-70. PubMed ID: 21348383
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
Wong CF; McCarthy M; Howse ML; Williams PS
Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
[TBL] [Abstract][Full Text] [Related]
9. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
[TBL] [Abstract][Full Text] [Related]
10. Initiating renal replacement therapy through incremental haemodialysis: Protocol for a randomized multicentre clinical trial.
Fernández Lucas M; Ruíz-Roso G; Merino JL; Sánchez R; Bouarich H; Herrero JA; Muriel A; Zamora J; Collado A
Trials; 2020 Feb; 21(1):206. PubMed ID: 32075665
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal dialysis in infants: the experience of the Italian Registry of Paediatric Chronic Dialysis.
Vidal E; Edefonti A; Murer L; Gianoglio B; Maringhini S; Pecoraro C; Sorino P; Leozappa G; Lavoratti G; Ratsch IM; Chimenz R; Verrina E;
Nephrol Dial Transplant; 2012 Jan; 27(1):388-95. PubMed ID: 21669887
[TBL] [Abstract][Full Text] [Related]
12. Epoetin responsiveness in peritoneal dialysis patients: a multi-center Slovenian study.
Pajek J; Bucar-Pajek M; Grego K; Gucek A; Bevc S; Ekart R; Vujkovac B; Golob-Kosmina P; Kandus A; Bren AF
Ther Apher Dial; 2005 Jun; 9(3):228-32. PubMed ID: 15966995
[TBL] [Abstract][Full Text] [Related]
13. [Middle molecules removal. Beyond beta2-microglobulin].
Maduell F; Sánchez-Canel JJ; Blasco JA; Navarro V; Ríus A; Torregrosa E; Pin MT; Cruz C; Ferrero JA
Nefrologia; 2006; 26(4):469-75. PubMed ID: 17058859
[TBL] [Abstract][Full Text] [Related]
14. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
[TBL] [Abstract][Full Text] [Related]
15. Phosphate handling by end-stage kidneys and benefits of residual renal function on phosphate removal in patients on haemodialysis.
Iwasawa H; Nakao T; Matsumoto H; Okada T; Nagaoka Y; Wada T
Nephrology (Carlton); 2013 Apr; 18(4):285-91. PubMed ID: 23432763
[TBL] [Abstract][Full Text] [Related]
16. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
Kim S; Oh J; Kim S; Chung W; Ahn C; Kim SG; Oh KH
Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384
[TBL] [Abstract][Full Text] [Related]
17. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
Lin JL; Lin-Tan DT; Hsu KH; Yu CC
N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640
[TBL] [Abstract][Full Text] [Related]
18. Estimation of residual glomerular filtration rate in peritoneal dialysis patients using cystatin C: comparison with 51Cr-EDTA clearance.
Carter JL; Lane CE; Fan SL; Lamb EJ
Nephrol Dial Transplant; 2011 Nov; 26(11):3729-32. PubMed ID: 21441400
[TBL] [Abstract][Full Text] [Related]
19. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function.
Wang AY; Woo J; Wang M; Sea MM; Sanderson JE; Lui SF; Li PK
Nephrol Dial Transplant; 2005 Feb; 20(2):396-403. PubMed ID: 15187196
[TBL] [Abstract][Full Text] [Related]
20. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
